세계의 안구표면질환 시장에 대해 조사했으며, 질환의 개요와 함께 부문별 동향, 치료법, 진단약, 생물제제의 사용 동향 등에 대해 정리하여 전해드립니다.
Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July and August 2024 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.
Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.
An email invitation was sent on July 26, 2024, and a last call went out on Aug. 23, 2024. We received 149 total complete, unique responses-116 from the US and 33 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.
Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.
Questions included in the survey were developed by Market Scope in combination with companies that sponsor the survey. Question topics included, but were not limited to, the following: